Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page Not Available ()Premium Content

Shire Plc (SHPG)

2014-12-18@02:01:24 ET
BioTime Adds Angus Russell to Board (CLM)

2014-12-17@18:34:58 ET
8-K: Shire plc (EDK)

2014-12-15@08:38:00 ET
BioTime Appoints Angus C. Russell to Board of Directors (BIZ)

2014-12-15@07:20:03 ET
Quarterly Changes to the NXTQ Index (PMZ)

2014-12-11@07:45:55 ET
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update (MTO)

2014-12-08@09:30:00 ET
Zacks Industry Outlook Highlights: AbbVie, Shire, Medtronic and Walgreen (PRN)

2014-12-05@07:10:14 ET
Will MedTech Gain from Republican Promises? (ZAX)

2014-12-05@07:10:08 ET
Will MedTech Gain from Republican Promises? (ZAX)

2014-12-02@07:30:22 ET
Dimension Therapeutics Expands Leadership Team, Names Eric Crombez, M.D., as Chief Medical Officer (BIZ)

2014-12-01@07:30:00 ET
Shire to Highlight Pipeline Progress and Breadth of Innovative Portfolio in R&D Day (PRN)

2014-11-27@06:19:54 ET
Shire to relocate over 500 jobs from Chesterbrook to Lexington (DTM)

2014-11-26@18:59:45 ET
Shire's Clear and Focused Strategy Delivers Record Quarterly Revenues. Non GAAP Diluted Earnings per ADS up 60% (EUR)

2014-11-26@17:00:34 ET
Shire plc: AbbVie Terminates Offer for Shire (EUR)

2014-11-26@16:25:44 ET
Interim Chief Financial Officer James Bowling to Step Down (EUR)

2014-11-26@15:21:13 ET
Shire plc: Statement re: AbbVie's Withdrawal of Recommendation (EUR)

2014-11-26@15:16:39 ET
AbbVie Board Recommends Stockholders Vote Against Shire Transaction (EUR)

2014-11-26@15:13:03 ET
Shire plc: Statement re: Waiver of Notice of AbbVie's Board Meeting (EUR)

2014-11-26@14:38:12 ET
Shire plc: Statement re: AbbVie's Intention to Reconsider Recommendation (EUR)

2014-11-26@14:32:52 ET
Announcement Of Notice To Shire Of AbbVie Board Intention To Reconsider Recommendation (EUR)

2014-11-26@12:13:59 ET
Shire Provides Regulatory Update on SHP 465, Investigational Compound for ADHD in Adults (EUR)